)
Edge6 Mar 2026
Upvoted: The Story of Reddit
How Reddit built a unique platform around communities and conversation, turning human insight and intent into a distinctive business model.
QuidelOrtho
QuidelOrtho (QDEL) investor relations material
QuidelOrtho 47th Annual Raymond James Institutional Investor Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.47th Annual Raymond James Institutional Investor Conference summary3 Mar, 2026
Strategic Positioning and Market Overview
Holds differentiated positions in attractive diagnostic segments, targeting sustainable long-term growth through innovation, execution, and disciplined capital management.
Portfolio covers the full continuum of care, with over 145,000 instruments in 140 countries and 75,000 customers; North America accounts for 55% of revenue.
Recurring revenue represents 96% of total, providing strong visibility and margin expansion potential.
Leading in core lab, immunohematology, and point-of-care segments, with innovative platforms and high customer retention rates.
Positioned to benefit from trends such as an aging population, decentralization of healthcare, and growth in emerging markets.
Innovation, Product Launches, and Acquisitions
Broad product portfolio includes VITROS, ORTHO VISION, SOFIA, TRIAGE, QUICKVUE, and LYRA platforms, addressing labs, immunohematology, and point-of-care needs.
Molecular diagnostics market has grown 2.5x since 2019; expanding presence with the acquisition of Lex Diagnostics, aiming for a 2026/2027 launch and FDA 510(k)/CLIA waiver clearance in February 2026.
Over 45 new assays and multiple new instrument launches planned to expand menu and automation capabilities, including VITROS 450 and High-Sensitivity Troponin Assay.
Expanding immunoassay menu with over 25 new assays via partnerships, maintaining leadership in blood typing and point-of-care respiratory testing.
Financial Performance and Outlook
FY25 revenue reported at $2.73 billion (5% growth ex-COVID/donor screening), $597 million adjusted EBITDA (22% margin), and $2.12 adjusted diluted EPS (15% growth).
FY26 guidance projects $2.9 billion in revenue, adjusted EBITDA of $630M–$670M, and adjusted diluted EPS of $2.00–$2.42.
Free cash flow expected to reach $120M–$160M in FY26, with a target of 50% run-rate FCF to adjusted EBITDA conversion by 2H27.
2026 guidance projects further margin expansion (130 bps), significant free cash flow growth from -$77 million to +$140 million, and a $217 million increase at midpoint.
Adjusted EBITDA margin expansion targeted to reach mid- to high-20% by mid-2027, with net debt leverage goal of 2.5x–3.5x.
Lex Diagnostics' 2027 revenue and margin impact
Key drivers for 2027 net debt leverage target?
VITROS 450's role in OUS market share growth?
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Next QuidelOrtho earnings date
Q1 20266 May, 2026
QuidelOrtho
Next QuidelOrtho earnings date
Q1 20266 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Quidel Corporation develops, manufactures and markets diagnostic testing solutions that can produce rapid and accurate clinical results to aid in the diagnosis of critical medical conditions. Rapid, accurate point of care tests are used by physicians and other healthcare providers to rapidly detect a variety of medical conditions. Quidel's products range from simple diagnostic screeners to more sophisticated multiple-analyte tests designed to be performed on Quidel's automated workstations.
Quidel manufactures its products and operates its sales and marketing operations primarily in San Diego, California and provides quality service and technical support through trained customer service representatives worldwide. Quidel Corporation was incorporated in 1979 and is headquartered in San Diego, California.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage